Consistent with the above-mentioned expression of CDK1, our study also identified that CDK1 overexpression was associated with YOD1 both in vitro and in vivo, playing a regulatory role in cell cycle, proliferation, migration and invasion of tumor cells, and drug resistance. The gene discussed is YOD1; the disease is neoplasm.